Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Rochester Medical files PMA for FemSoft

Jan. 22, 1999

Improved treatments for BPH in development at Pfizer

Jan. 22, 1999

SNAP-5540: a uroselective adrenergic BPH agent

Jan. 20, 1999

Ortho-McNeil reports new treatments for BPH

Jan. 20, 1999

Lilly's new 5-HT1D agonists claimed for CNS and bladder disorders

Jan. 4, 1999

OPC-31260: potential utility in cirrhosis patients with impaired water handling

Dec. 30, 1998

Tobishi's pollen extract improves bladder dysfunction, nonbacterial prostatitis in rats

Dec. 21, 1998

FDA clears first and only once-daily treatment for overactive bladder

Dec. 21, 1998

New agents for micturition disorders discovered at Kyowa Hakko

Dec. 16, 1998

Vanguard drops hyperphosphatemia Rx from development pipeline

Dec. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...